ArticleBlood cancer journal2015

T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330.

G S Laszlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.